BaltaSCakarMDemirkolSArslanZAkhanM. Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome. Clin Appl Thromb Hemost. 2013;19:579.
2.
YalcinMAparciMUzO. Neutrophil-lymphocyte ratio may predict left atrial thrombus in patients with nonvalvular atrial fibrillation. Clin Appl Thromb Hemost. 2015;21:166–71.
3.
GasparyanAYAyvazyanLMikhailidisDPKitasGD. Mean platelet volume: a link between thrombosis and inflammation?Curr Pharm Des. 2011;17:47–58.
4.
ChoiD-HKobayashiYNishiTSongHFearonWF. Lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention. Angiology. 2018.
5.
AkinFAyçaBKöseN. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia. Angiology. 2013;64:621–5.
6.
BaltaSMikhailidisDPKurtogluEDemirkolS. Mean platelet volume in patients undergoing percutaneous coronary intervention. Platelets. 2015;26:269–70.
7.
UsluAUInalSBaltaS. Assessment of platelet-lymphocyte ratio based on EDTA-dependent pseudothrombocytopenia. Angiology. 2016;67:96–7.
8.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22:405–11.
9.
OzturkCBaltaSBaltaI. Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement. Angiology. 2015;66:291–6.
10.
FiciFCelikTBaltaS. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol. 2013;62:388–93.
